Australia - angielski - Department of Health (Therapeutic Goods Administration)

the better health company (australia) pty - honey, quantity: 50 mg; citrus bioflavonoids extract, quantity: 25 mg; sodium ascorbate, quantity: 359.96 mg (equivalent: ascorbic acid, qty 320 mg); ascorbic acid, quantity: 180 mg - tablet, chewable - excipient ingredients: maltodextrin; maize starch; hypromellose; glucose monohydrate; sucralose; magnesium stearate; colloidal anhydrous silica; flavour - antioxidant/reduce free radicals formed in the body ; helps reduce/decrease free radical damage to body cells ; maintain/support collagen formation ; maintain/support general health and wellbeing ; maintain/support healthy teeth ; maintain/support connective tissue health ; aid/assist/helps connective tissue production/formation ; maintain/support bone health ; maintain/support blood capillary health ; maintain/support blood vessel health ; maintain/support immune system health ; maintain/support healthy immune system function ; maintain/support absorption of dietary (state vitamin/mineral/nutrient) ; helps prevent dietary (state vitamin/mineral/nutrient) deficiency ; aid/assist/helps synthesis of neurotransmitters ; maintain/support nervous system health ; maintain/support nervous system function ; decrease/reduce/relieve common cold duration ; decrease/reduce/relieve the severity of common cold symptoms ; maintain/support skin health ; maintain/support wound healing

Australia - angielski - Department of Health (Therapeutic Goods Administration)

the better health company (australia) pty - astaxanthin esters extracted from haematococcus pluvialis, quantity: 120 mg (equivalent: astaxanthin (of haematococcus pluvialis), qty 6 mg); d-alpha-tocopherol, quantity: 7 mg; ascorbic acid, quantity: 50 mg - capsule, soft - excipient ingredients: yellow beeswax; olive oil; gelatin; glycerol; purified water; iron oxide red; sorbitol solution (70 per cent) (non-crystallising) - antioxidant/reduce free radicals formed in the body ; helps reduce/decrease free radical damage to body cells ; maintain/support collagen formation ; maintain/support general health and wellbeing ; maintain/support healthy teeth ; maintain/support connective tissue health ; aid/assist/helps connective tissue production/formation ; maintain/support bone health ; maintain/support blood capillary health ; maintain/support blood vessel health ; maintain/support immune system health ; maintain/support healthy immune system function ; maintain/support absorption of dietary (state vitamin/mineral/nutrient) ; helps prevent dietary (state vitamin/mineral/nutrient) deficiency ; aid/assist/helps synthesis of neurotransmitters ; maintain/support nervous system health ; maintain/support nervous system function ; maintain/support skin health ; maintain/support wound healing

Australia - angielski - Department of Health (Therapeutic Goods Administration)

amdipharm mercury australia pty ltd - nortriptyline hydrochloride, quantity: 11.4 mg (equivalent: nortriptyline, qty 10 mg) - tablet, uncoated - excipient ingredients: lactose monohydrate; magnesium stearate; maize starch - treatment of major depression

Australia - angielski - Department of Health (Therapeutic Goods Administration)

amdipharm mercury australia pty ltd - nortriptyline hydrochloride, quantity: 28.5 mg (equivalent: nortriptyline, qty 25 mg) - tablet, uncoated - excipient ingredients: maize starch; lactose monohydrate; magnesium stearate - treatment of major depression

Australia - angielski - Department of Health (Therapeutic Goods Administration)

the better health company (australia) pty - propolis dry extract, quantity: 200 mg (equivalent: propolis, qty 1 g; equivalent: lead, qty 2 microgram) - capsule, soft - excipient ingredients: d-alpha-tocopherol; soya oil; carob pod; yellow beeswax; lecithin; gelatin; glycerol; iron oxide black; iron oxide red; purified water; vanillin - antioxidant/reduce free radicals formed in the body ; maintain/support general health and wellbeing ; maintain/support healthy immune system function

Australia - angielski - Department of Health (Therapeutic Goods Administration)

the better health company (australia) pty - passiflora incarnata, quantity: 125 mg (equivalent: passiflora incarnata, qty 500 mg); vitex agnus-castus, quantity: 150 mg (equivalent: vitex agnus-castus, qty 1.5 g) - capsule, hard - excipient ingredients: microcrystalline cellulose; colloidal anhydrous silica; maltodextrin; magnesium stearate; titanium dioxide; hypromellose; potable water - maintain/support general health and wellbeing ; traditionally used in western herbal medicine to antispasmodic/spasmolytic ; traditionally used in western herbal medicine to decrease/reduce/relieve restlessness/excess nervous energy ; traditionally used in western herbal medicine to decrease/reduce/relieve nervous tension/unrest ; traditionally used in western herbal medicine to helps decrease/reduce/relieve symptoms of mild tension headache ; traditionally used in western herbal medicine to calmative/nervous system relaxant ; traditionally used in western herbal medicine to nervine/support nervous system ; traditionally used in western herbal medicine to decrease/reduce/relieve mild nerve pain/neuralgia ; traditionally used in western herbal medicine to soporific/induces sleep ; traditionally used in western herbal medicine to decrease/reduce/relieve disturbed/restless sleep ; traditionally used in western herbal medicine to haemagogue/emmenagogue/promotes menstrual flow ; traditionally used in we

Stany Zjednoczone - angielski - NLM (National Library of Medicine)

h.j. harkins company, inc. - amitriptyline hydrochloride (unii: 26lud4jo9k) (amitriptyline - unii:1806d8d52k) - amitriptyline hydrochloride 10 mg - for the relief of symptoms of depression. endogenous depression is more likely to be alleviated than are other depressive states. amitriptyline hydrochloride is contraindicated in patients who have shown prior hypersensitivity to it. it should not be given concomitantly with monoamine oxidase inhibitors. hyperpyretic crises, severe convulsions, and deaths have occurred in patients receiving tricyclic antidepressant and monoamine oxidase inhibiting drugs simultaneously. when it is desired to replace a monoamine oxidase inhibitor with amitriptyline hydrochloride, a minimum of 14 days should be allowed to elapse after the former is discontinued. amitriptyline hydrochloride should then be initiated cautiously with gradual increase in dosage until optimum response is achieved. amitriptyline hydrochloride should not be given with cisapride due to the potential for increased qt interval and increased risk for arrhythmia. this drug is not recommended for use during the acute recovery phase following myocardial infarc

Stany Zjednoczone - angielski - NLM (National Library of Medicine)

american health packaging - nortriptyline hydrochloride (unii: 00fn6ih15d) (nortriptyline - unii:bl03sy4lxb) - nortriptyline 10 mg - nortriptyline hydrochloride is indicated for the relief of symptoms of depression. endogenous depressions are more likely to be alleviated than are other depressive states. the use of maois intended to treat psychiatric disorders with nortriptyline hydrochloride or within 14 days of stopping treatment with nortriptyline hydrochloride is contraindicated because of an increased risk of serotonin syndrome. the use of nortriptyline hydrochloride within 14 days of stopping an maoi intended to treat psychiatric disorders is also contraindicated ( see warnings and dosage and administration ). starting nortriptyline hydrochloride in a patient who is being treated with maois such as linezolid or intravenous methylene blue is also contraindicated because of an increased risk of serotonin syndrome ( see warnings and dosage and administration ). cross-sensitivity between nortriptyline hydrochloride and other dibenzazepines is a possibility. nortriptyline hydrochloride is contraindicated during the acute recov

Australia - angielski - Department of Health (Therapeutic Goods Administration)

the better health company (australia) pty - astaxanthin esters extracted from haematococcus pluvialis,colecalciferol,docosahexaenoic acid (dha)-rich oil derived from microalgae schizochytrium sp.,tagetes erecta -

Australia - angielski - Department of Health (Therapeutic Goods Administration)

the better health company (australia) pty - astaxanthin esters extracted from haematococcus pluvialis,colecalciferol,docosahexaenoic acid (dha)-rich oil derived from microalgae schizochytrium sp.,tagetes erecta -